| Nicholas Matthew Adamo, MD | |
|
1 Cooper Plz, Camden, NJ 08103-1461 | |
| (800) 826-6737 | |
| Not Available |
| Full Name | Nicholas Matthew Adamo |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1 Cooper Plz, Camden, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033767454 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 323337 (New York) | Primary |
| Entity Name | Mccd Psychiatry Services Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033750823 PECOS PAC ID: 4082049036 Enrollment ID: O20200121001374 |
News Archive
Scientists have for the first time discovered a mechanism that limits the number of "cellular janitors" in the nervous system, leading to increased risk for two neurodegenerative diseases: amyotrophic lateral sclerosis and frontotemporal dementia, according to a Keck School of Medicine of USC study published today in Nature Medicine.
With an estimated 25% of people worldwide affected by nonalcoholic fatty liver disease (NAFLD), there is a large unmet need for accurate, noninvasive measures to enhance early diagnosis and screening of hepatic fibrosis.
Boston University School of Medicine (BUSM) is one of five institutions receiving funding from the Aetna Foundation to support research designed to deepen understanding of the root causes of the nation's well-documented obesity epidemic and drive viable solutions to the core problems. More than $1 million in funding will be granted in support of separate studies at BUSM, New York University School of Medicine, the University of Michigan, the University of Pennsylvania and Yale University's CARE program.
UK diagnostics firm Salient Bio has announced the commercial roll out of its robotics driven COVID-19 mass testing platform.
Zimmer Holdings, Inc. today reported financial results for the fourth quarter and year ended December 31, 2009. The Company reported fourth quarter net sales of $1.11 billion, an increase of 7.5% reported and 2.5% constant currency over the fourth quarter of 2008. Diluted earnings per share for the quarter were $0.74 reported and $1.12 adjusted, an increase of 12.0% adjusted over the prior year period.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicholas Matthew Adamo, MD 1 Cooper Plz, Camden, NJ 08103-1461 Ph: () - | Nicholas Matthew Adamo, MD 1 Cooper Plz, Camden, NJ 08103-1461 Ph: (800) 826-6737 |
News Archive
Scientists have for the first time discovered a mechanism that limits the number of "cellular janitors" in the nervous system, leading to increased risk for two neurodegenerative diseases: amyotrophic lateral sclerosis and frontotemporal dementia, according to a Keck School of Medicine of USC study published today in Nature Medicine.
With an estimated 25% of people worldwide affected by nonalcoholic fatty liver disease (NAFLD), there is a large unmet need for accurate, noninvasive measures to enhance early diagnosis and screening of hepatic fibrosis.
Boston University School of Medicine (BUSM) is one of five institutions receiving funding from the Aetna Foundation to support research designed to deepen understanding of the root causes of the nation's well-documented obesity epidemic and drive viable solutions to the core problems. More than $1 million in funding will be granted in support of separate studies at BUSM, New York University School of Medicine, the University of Michigan, the University of Pennsylvania and Yale University's CARE program.
UK diagnostics firm Salient Bio has announced the commercial roll out of its robotics driven COVID-19 mass testing platform.
Zimmer Holdings, Inc. today reported financial results for the fourth quarter and year ended December 31, 2009. The Company reported fourth quarter net sales of $1.11 billion, an increase of 7.5% reported and 2.5% constant currency over the fourth quarter of 2008. Diluted earnings per share for the quarter were $0.74 reported and $1.12 adjusted, an increase of 12.0% adjusted over the prior year period.
› Verified 4 days ago
Dr. Thomas Denton Demark, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3 Cooper Plz, Suite 307, Camden, NJ 08103 Phone: 856-342-2328 Fax: 856-541-6137 | |
Pamela Szeeley, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz, Suite 307, Camden, NJ 08103 Phone: 856-968-7433 | |
John E Bevilacqua, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3 Cooper Plz, Suite 320, Camden, NJ 08103 Phone: 856-616-1337 | |
Dr. Michael H Goodman, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3 Cooper Plz, Suite 200, Camden, NJ 08103 Phone: 856-342-2001 Fax: 856-968-2499 | |
Yingcheng Xu, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz Rm 307, Camden, NJ 08103 Phone: 856-342-2328 | |
Teresa J Humaran, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3 Cooper Plz, Suite 307, Camden, NJ 08103 Phone: 856-342-2328 Fax: 856-541-6137 |